NOVOZYMES BIOINDUSTRIAL A/S: Financial statements 2016
CVR: 24257908
Source: annual report 2016, Danish Business Authority
01/01/2016 – 31/12/2016
NOVOZYMES BIOINDUSTRIAL A/S (CVR 24257908) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK -77,546 and a net result of DKK 254,382 compared with DKK -1,318,202 the year before. Equity in the 2016 report amounted to DKK 6,558,998. The solvency ratio was 21.1%.
- Gross Profit
- DKK -77,546
- Profit/Loss
- DKK 254,382
- Equity
- DKK 6,558,998
- Total Assets
- DKK 31,094,066
Official annual report
Find more companies like NOVOZYMES BIOINDUSTRIAL A/S
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2016
As of September 16, 2016, Randi Camilla Kinch Jensen is registered as adm. dir. of NOVOZYMES BIOINDUSTRIAL A/S.
As of September 16, 2016, Benny Dalgaard Loft has stepped down as adm. dir. of NOVOZYMES BIOINDUSTRIAL A/S.
NOVOZYMES BIOINDUSTRIAL A/S has published its annual report for 2015. Gross profit came to DKK -947,854, and the net result was DKK -1,318,202.
About NOVOZYMES BIOINDUSTRIAL A/S
NOVOZYMES BIOINDUSTRIAL A/S is a Danish company of the type Aktieselskab based in Bagsværd, founded in 1974. The company is registered under the industry Ikke-finansielle holdingselskaber. The company was previously named NOVO NORDISK BIOINDUSTRIAL A/S and NOVO ENZYM A/S. The management consists of Lisbet Kragelund. The board consists of Mikkel Viltoft (chair), Lisbet Kragelund and Rainer Chapour Lehmann. The company is owned by NOVOZYMES A/S. According to the 2022 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -52,056 and a net result of DKK -44,180 compared with DKK -41,700 the year before. Equity in the 2025 report amounted to DKK 24,891,057.